Congenital Cytomegalovirus Among Newborns in Neonatal Intensive Care Units, United States, 2010–2020
Birth Defects Research · 2026-07 · 118 (7)
DOI: 10.1002/bdr2.70092 ↗At a glance
Journal article in Birth Defects Research, published online on 2026-07-23. Written by Kelley Raines and 6 co-authors. Institution: Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, …. Major MEDLINE topics: Cytomegalovirus Infections, Cytomegalovirus. 28 references. The full text is freely available in PubMed Central.
Topics: Neonatologie, Intensivpflege
Abstract (original language)
Introduction
Little is known about routine testing practices and diagnosis of congenital cytomegalovirus (cCMV) infection in newborns admitted to neonatal intensive care units (NICUs) across the United States. We assessed demographics and clinical signs associated with cCMV testing and diagnosis in newborns admitted to US NICUs.
Methods
We analyzed Pediatrix Clinical Data Warehouse data, comprising 840,988 newborns admitted to 389 NICUs in 35 states during 2010–2020. We defined cCMV testing as culture or PCR performed on urine, saliva, blood, or cerebrospinal fluid collected within 21 days of life, and a positive result (except in saliva) as cCMV infection diagnosis. Logistic regression models examined associations between clinical signs and cCMV testing and diagnosis separately, adjusting for region, birth year, and prematurity.
Results
Among 10,033 (1.2%) newborns tested (67.7% by culture; 79.8% using urine), 559 (5.6%) were diagnosed with cCMV infection. During 2010–2020, among those tested, the proportion with ≤ 1 clinical sign increased from 12.9% to 32.0%. Hepatosplenomegaly, petechiae, microcephaly, hepatitis, thrombocytopenia, chorioretinitis, and intracranial calcifications were associated with increased odds of both cCMV testing and diagnosis, with varying specificity.
Conclusions
Despite low CMV testing rates in the NICU, a shift toward testing newborns with fewer clinical signs occurred over time.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- The Center for Research, Education, and Quality Improvement, Pediatrix Medical Group, Sunrise, Florida, USA.
- Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
ORCID profiles: Kate R Woodworth, Tatiana M Lanzieri
Cite
APA
Raines, K., Rau, A., Clark, R., Woodworth, K. R., Tong, V. T., Sugerman, D., & Lanzieri, T. M. (2026). Congenital Cytomegalovirus Among Newborns in Neonatal Intensive Care Units, United States, 2010–2020. Birth Defects Research, 118(7). https://doi.org/10.1002/bdr2.70092
Vancouver
Raines K, Rau A, Clark R, Woodworth KR, Tong VT, Sugerman D, et al. Congenital Cytomegalovirus Among Newborns in Neonatal Intensive Care Units, United States, 2010–2020. Birth Defects Research. 2026;118(7). doi:10.1002/bdr2.70092
BibTeX
@article{Raines2026,
author = {Raines, Kelley and Rau, Ashrita and Clark, Reese and Woodworth, Kate R and Tong, Van T and Sugerman, David and Lanzieri, Tatiana M},
title = {Congenital Cytomegalovirus Among Newborns in Neonatal Intensive Care Units, United States, 2010–2020},
journal = {Birth Defects Research},
year = {2026},
volume = {118},
number = {7},
doi = {10.1002/bdr2.70092}
}
EUVIMED